Drew Ranieri

Stock Analyst at Morgan Stanley

(1.19)
# 3,745
Out of 5,045 analysts
167
Total ratings
44.44%
Success rate
-12.48%
Average return

Stocks Rated by Drew Ranieri

Globus Medical
Jul 15, 2025
Maintains: Overweight
Price Target: $75$68
Current: $60.72
Upside: +11.99%
Organogenesis Holdings
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $4$6
Current: $4.23
Upside: +41.84%
Alphatec Holdings
Dec 2, 2024
Assumes: Equal-Weight
Price Target: $9.5$10
Current: $16.33
Upside: -38.76%
Stryker
Dec 2, 2024
Upgrades: Overweight
Price Target: $370$445
Current: $368.98
Upside: +20.60%
SI-BONE
Aug 6, 2024
Maintains: Overweight
Price Target: $21$19
Current: $15.15
Upside: +25.41%
Integra LifeSciences Holdings
Jul 15, 2024
Maintains: Underweight
Price Target: $24$27
Current: $11.81
Upside: +128.62%
Treace Medical Concepts
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $5.5$8
Current: $6.35
Upside: +25.98%
Stevanato Group
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $26$22
Current: $24.94
Upside: -11.79%
NeuroPace
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $9.5$8
Current: $9.86
Upside: -18.86%
Outset Medical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $75$83
Current: $12.63
Upside: +553.21%
Maintains: Overweight
Price Target: $42$38
Current: $20.14
Upside: +88.68%
Maintains: Equal-Weight
Price Target: $88$96
Current: $49.99
Upside: +92.04%
Maintains: Underweight
Price Target: $28$26
Current: $11.14
Upside: +133.39%
Maintains: Overweight
Price Target: $290$295
Current: $179.38
Upside: +64.46%
Maintains: Equal-Weight
Price Target: $236$280
Current: $124.84
Upside: +124.29%
Maintains: Overweight
Price Target: $11$5
Current: $6.77
Upside: -26.14%
Maintains: Overweight
Price Target: $72$70
Current: $19.16
Upside: +265.34%
Maintains: Equal-Weight
Price Target: $325$300
Current: $530.02
Upside: -43.40%